James C. D'Arecca
Chief Accounting Officer
Haemonetics Corp (HAE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James C. D'Arecca
James C. D'Arecca is recorded as Chief Accounting Officer and CFO at Haemonetics Corp (HAE). Haemonetics Corp reported in an 8-K filed August 8, 2022 that James C. D'Arecca was appointed principal accounting officer, effective August 5, 2022. The proxy statement of Haemonetics Corp reports total compensation of $3,623,016 for James C. D'Arecca in fiscal 2026, including a base salary of $603,698. Disclosed compensation is on record for 5 fiscal years.
“On August 5, 2022, the Board of Directors of Haemonetics Corporation (the "Company") appointed James C. D'Arecca, Executive Vice President, Chief Financial Officer, as the Company's principal accounting officer in connection with the previously reported departure of Dan Goldstein, Vice President, Corporate Controller, on or about August 9, 2022.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-08-05–present
-
Current
2022-04-11–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Haemonetics Corp
Other people whose current roles at this company are on record from its filings.
- Christopher A. Simon CEO, Board Member
- Christopher Simon CEO, Board Member
- Ellen M. Zane Chairman
- James D'Arecca CFO
- Frank W. Chan COO
- Frank W. Chan, Ph.D. COO
- Anila Lingamneni CTO
- Michelle L. Basil General Counsel
- Maryanne Farris Chief Accounting Officer
- Claire Pomeroy Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Haemonetics Corp (HAE) | Executive Vice President, Chief Financial Officer | $603,698 | $3,623,016 |
| 2025 | Haemonetics Corp (HAE) | Executive Vice President, Chief Financial Officer | $575,582 | $2,975,669 |
| 2024 | Haemonetics Corp (HAE) | Executive Vice President, Chief Financial Officer | $548,213 | $3,146,059 |
| 2023 | Haemonetics Corp (HAE) | Executive Vice President, Chief Financial Officer | $525,000 | $3,764,650 |
| 2022 | Haemonetics Corp (HAE) | Executive Vice President, Chief Financial Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.